Dietary supplements should not be considered alternatives to prescription GLP-1 medications, and consumers should not expect comparable outcomes
Spontaneous spinal cerebrospinal fluid leaks and intracranial hypotension
We further examined whether acute tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist recently approved by the FDA for obesity, and retatrutide, an investigational triple agonist targeting GIP, GLP-1, and glucagon receptors currently in Phase 3 trials would recapitulate or enhance these effects
Using spatial transcriptomics, GPX4 has been identified to be located at the interface between the inner cortex and the outer medulla of the kidney, which is the main site of cell ferroptosis after I/R injury
#GLP1 #Inflammation #Metabolism #Biotech #HealthcareInnovation #DrugMechanism #ChronicDisease Impact of Glp-1 Medications on Health Explore top LinkedIn content from expert professionals
,